Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) showing promising early weight-loss and metabolic data in Phase 2 trials, but it is not yet approved in the UK and carries notable side effects and safety uncertainties
You take a gel, wait 30 to 45 minutes for it to clear your stomach and liver, and hope the timing works out
Researchers select GHK-Cu for its relevance in studying cellular communication, copper-binding mechanisms, and molecular signaling pathways in controlled experimental models
CagriSema combined semaglutide, the active ingredient in Novo Nordisks Wegovy, with the molecule cagrilintide, which mimics the pancreatic hormone amylin
2017;114(43):E908695
GHK also increased gene expression of MMP1 and MMP2 at the 0.01 nM